SCHEMBL29960935

SCHEMBL29960935

CNC(=O)c1ccc(C(=O)Nc2cc(N)ccc2OC)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.61
TP53 P04637 1/20 0.61
HDAC1 Q13547 5/20 0.56
HDAC8 Q9BY41 5/20 0.56
HDAC6 Q9UBN7 5/20 0.56
MAPT P10636 4/20 0.55
MAPK1 P28482 2/20 0.55
KDM4E B2RXH2 2/20 0.53
TSHR P16473 1/20 0.53
ALDH1A1 P00352 1/20 0.53
HTT P42858 1/20 0.53
RAD52 P43351 1/20 0.51
GFER P55789 1/20 0.51
RECQL P46063 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
PYGL P06737 1/20 0.50
MEN1 O00255 1/20 0.50
LMNA P02545 1/20 0.50
KMT2A Q03164 1/20 0.50
CYP1A2 P05177 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10605968 0.93 GAA (0.66) GAATP53HDAC1HDAC8HDAC6
SCHEMBL28863360 0.89 ALDH1A1 (0.62) GAATP53HDAC1HDAC8HDAC6
SCHEMBL9335190 0.87 GAA (0.59) GAATP53HDAC1HDAC8HDAC6
SCHEMBL11506084 0.87 HDAC1 (0.68) GAATP53HDAC1HDAC8HDAC6
SCHEMBL7303802 0.86 NR1H4 (0.62) GAATP53HDAC1HDAC8HDAC6
Hydrochloric Acid SCHEMBL11414769 0.86 HDAC1 (0.67) GAATP53HDAC1HDAC8HDAC6
SCHEMBL20578214 0.83 TP53 (0.83) GAATP53HDAC1HDAC8HDAC6
SCHEMBL31114178 0.83 MAPT (0.57) GAATP53HDAC1HDAC8HDAC6
SCHEMBL29960273 0.81 MAPT (0.57) GAATP53HDAC1HDAC8HDAC6
SCHEMBL345880 0.81 MAPT (0.63) GAATP53MAPTMAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240158355-A1 BET SUBFAMILY INHIBITORS AND METHODS USING SAME BAYLOR COLLEGE MEDICINE (US) 2024-05-16 US disclosed
WO-2022159454-A1 BET SUBFAMILY INHIBITORS AND METHODS USING SAME BAYLOR COLLEGE OF MEDICINE (US) 2022-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240158355-A1 BET SUBFAMILY INHIBITORS AND METHODS USING SAME BRDT, BRD3, BRD2 GAA 4227/4885TP53 1031/4885HDAC1 87/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.